These primary prostate cancer stromal cells or PrCSCs are FAP-, CD90-, CD105-, and CD73-positive in the absence of CD14, CD20, CD34, CD45, and HLA-DR expression. This evidence concerns the gene PTPRC and prostate carcinoma.